Back to MS MSD Partners, L.P.

WEWEK
19 quarters

Position history for MSMSD Partners, L.P.'s holdings in ZIOPHARM ONCOLOGY INC

As of its Q4 2023 13F, MSD Partners held 15,151,516 shares of WEK (Ziopharm Oncology), worth $1.1M. MSD Partners' 13F filings listed WEK from Q3 2019 to Q4 2023, 18 quarterly filings. WEK was 0.1% of MSD Partners' reported 13F portfolio.

Final Value

$0

Final Shares

0

Total Value Change

-$64.8M

Total Shares Change

-15.2M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2024-Q1
Latest
Exited
0
-100.0%
$00.0%$5.28
0
2023-Q4
Unchanged
15.2M
0.0%
$1.1M0.1%$5.28
0
2023-Q3
Unchanged
15.2M
0.0%
$2M0.2%$5.28
0
2023-Q2
Unchanged
15.2M
0.0%
$7.7M0.7%$5.28
0
2023-Q1
Unchanged
15.2M
0.0%
$9.5M0.8%$5.28
0
2022-Q4
Unchanged
15.2M
0.0%
$9.8M1.0%$5.28
0
2022-Q3
Unchanged
15.2M
0.0%
$26.1M2.1%$5.28
0
2022-Q2
Unchanged
15.2M
0.0%
$18.8M1.2%$5.28
0
2022-Q1
Unchanged
15.2M
0.0%
$9.9M0.5%$5.28
0
2021-Q4
Unchanged
15.2M
0.0%
$16.5M1.4%$5.28
0
2021-Q3
Unchanged
15.2M
0.0%
$27.6M0.8%$5.28
0
2021-Q2
Unchanged
15.2M
0.0%
$40M1.0%$5.28
0
2021-Q1
Unchanged
15.2M
0.0%
$54.5M2.1%$5.28
0
2020-Q4
Unchanged
15.2M
0.0%
$38.2M6.4%$5.28
0
2020-Q3
Unchanged
15.2M
0.0%
$38.2M8.0%$5.28
0
2020-Q2
Unchanged
15.2M
0.0%
$49.7M12.7%$5.28
0
2020-Q1
Unchanged
15.2M
0.0%
$37.1M10.0%$5.28
0
2019-Q4
Unchanged
15.2M
0.0%
$71.5M15.7%$5.28
0
2019-Q3
First report
15.2M
-
$64.8M8.7%$5.28
0

Other major holders of WEK: MILLER VALUE PARTNERS, LLC, STATE STREET CORP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used